K. Eppert

发表

Stem cell gene expression programs influence clinical outcome in human leukemia

Angelo J. Canty, T. Golub, L. Waldron, 2011, Nature Medicine.

A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal.

E. Domany, O. Ornatsky, J. Dick, 2010, Cell stem cell.

Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas

K. Eppert, J. Wunder, I. Andrulis, 1999, Oncogene.

Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development

J. Dick, K. Eppert, F. Notta, 2010, Nature Immunology.

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

Kiran C. Bobba, Kimberly J. Johnson, Michael C. Rusch, 2012, Nature.

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.

Sébastien Lemieux, Patrick Gendron, Tobias Herold, 2016, Blood.

MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma

Irene L Andrulis, Stephen W Scherer, Steven Gallinger, 1996, Cell.

miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells

Gary D Bader, Stanley W. K. Ng, T. Golub, 2016, Cancer cell.

SAS is amplified predominantly in surface osteosarcoma

P. Meltzer, K. Eppert, I. Andrulis, 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation

N. Krogan, A. Haman, T. Hoang, 2019, Journal of Experimental & Clinical Cancer Research.

MYELOID NEOPLASIA GPR56 identi ﬁ es primary human acute myeloid leukemia cells with high repopulating potential in vivo

G. Boucher, J. Krosl, G. Sauvageau, 2016 .

Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia

Stanley W. K. Ng, K. Eppert, M. Minden, 2018, Blood Cancer Journal.

Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide

K. Eppert, B. Jean-Claude, J. Rak, 2019, Clinical Cancer Research.

Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors.

Anna Y. Lee, Eunice E. Cho, G. Giaever, 2013, The Journal of clinical investigation.

The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress

E. Laurenti, D. Kent, A. Krešo, 2014, Nature.

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells

L. Bullinger, J. Dick, K. Eppert, 2017, The Journal of clinical investigation.

Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras

K. Eppert, L. Montermini, J. Rak, 2016, Oncotarget.

Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness

R. Mahfouz, K. Eppert, M. Minden, 2019, Nature Communications.

Investigation of genes involved in osteosarcoma development

K. Eppert, Kolja Eppert, 1998 .

Comparison of human cord blood engraftment between immunocompromised mouse strains.

J. Dick, K. Eppert, E. Lechman, 2010, Blood.

Reduced lymphoid lineage priming promotes human hematopoietic stem cell expansion.

Jian-Bing Fan, E. Laurenti, A. Krešo, 2014, Cell stem cell.

Chapter 3 Reduced lymphoid lineage priming promotes human hematopoietic stem cell expansion

E. Laurenti, A. Krešo, K. Eppert, 2014 .

Altered expression and deletion of RMO1 in osteosarcoma

S. Scherer, L. Tsui, K. Eppert, 2005, International journal of cancer.

Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project

Kiran C. Bobba, Kimberly J. Johnson, R. Wilson, 2011 .

miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells

Gary D Bader, Stanley W. K. Ng, T. Golub, 2016, Cancer Cell.

CD200 expression marks leukemia stem cells in human AML.

Gary D Bader, J. Dick, K. Eppert, 2020, Blood advances.

Identification of existing bioactive molecules that target acute myeloid leukemia stem cells

Stanley W. K. Ng, J. Dick, K. Eppert, 2016 .

Targeting MYC Overexpressing Leukemia with Cardiac Glycoside Proscillaridin Through Downregulation of Histone Acetyltransferases

N. Krogan, A. Haman, T. Hoang, 2018, bioRxiv.

miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells

Gary D Bader, Stanley W. K. Ng, T. Golub, 2016, Cancer cell.

Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness

R. Mahfouz, K. Eppert, M. Minden, 2019, Nature Communications.

Complement cascade gene expression defines novel prognostic subgroups of acute myeloid leukemia.

W. Hiddemann, K. Eppert, S. Bohlander, 2016, Experimental hematology.

von Willebrand factor expression in osteosarcoma metastasis

K. Eppert, J. Wunder, I. Andrulis, 2005, Modern Pathology.

A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside.

J. Dick, K. Eppert, M. Minden, 2012, Blood.

Mir-126 Governs Human Leukemia Stem Cell Quiescence and Chemotherapy Resistance

Gary D Bader, Stanley W. K. Ng, Jun Lu, 2013 .

Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia

Stanley W. K. Ng, K. Eppert, M. Minden, 2018, Blood Cancer Journal.